Just Cheap

Fortune follows the Brave.

Those waiting for this company to do a capital raise, may well miss out on the opportunity of a lifetime.

All broker (Euroz-Canaccord and Petra) research factor in significant capital raises at these prices and still come up with valuations in the 45c to 65c range.

If the company can complete stage 1 with any non dilatory debt funding, these valuations should increase markedly.

The indications from the company are that the FS may well be profitable at the lows we hit for NdPr oxide prices several months ago.
This can only help any debt funding proposals.

If this is the case, any further increase in NdPr prices will prove to make this project a significant cash cow and the multiplier rewards will come to those that own shares now.

Brokers make money from 6% placements fees- not 0.5% brokerage- and that is their motivation, -- they may be right, but even if they are, the stock is still cheap and if they are wrong , real fortunes follow the brave.